PRL and cancer: KEGG enrichment analysis showed (Figure 3D) that 125 signaling pathways were mainly enriched in the chemical carcinogenesis-receptor activation pathways in cancer, the prolactin signaling pathway, the PI3K-AKT signaling pathway, and endocrine resistance.